DERMA • DERMA

ULCRIO

Choline Salicylate 8.7%w/w,Benzalkonium Chloride 0.01%w/w & Lignocaine Hcl 2%w/w Gel

Schedule H Prescription Drug
Printed MRP: ₹72.00 (Incl. of all taxes)
★ PCD Franchise Offer: Attractive Margins
Packaging Form
10gm
Standard Specification
IP / BP / USP Pharmacopoeial Standards
Brand Family
ULCRIO Series
Franchise Territory
District Monopoly Available
Order / Pay Online

Product Technical Snapshot

Official pharmaceutical registration and manufacturing parameters

Brand Name ULCRIO
Active Formulation (Salt) Choline Salicylate 8.7%w/w,Benzalkonium Chloride 0.01%w/w & Lignocaine Hcl 2%w/w Gel
Dosage Form DERMA
Packaging Presentation 10gm
Therapeutic Category DERMA
Regulatory Classification Schedule H Prescription Drug
Pharmacopoeial Standard IP / BP / USP Pharmacopoeial Standards
Quality Certifications WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
Marketed & Distributed By Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana)
B2B Franchise Availability Monopoly PCD Franchise rights available across all Indian districts

What is ULCRIO?

Therapeutic monograph and clinical profile

ULCRIO (Choline Salicylate 8.7%w/w,Benzalkonium Chloride 0.01%w/w & Lignocaine Hcl 2%w/w Gel) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 10gm, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Aphthous Ulcers & Painful Mouth Sores /Teething Pain & Denture Irritation.

Key Formulation Highlights

Why healthcare professionals recommend ULCRIO

WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
DCGI Approved Formulation with Proven Chemical Purity
High Bioavailability & Predictable Pharmacokinetics
Premium Moisture-Proof Protective Packaging
Exclusive Monopoly PCD Pharma Franchise Rights Available

Therapeutic Uses & Clinical Indications

Conditions and clinical disorders managed by this medicine

Recommended Clinical Indications:

Aphthous Ulcers & Painful Mouth Sores /Teething Pain & Denture Irritation

Pharmacological Mechanism of Action

How ULCRIO acts biochemically in the body

Delivers targeted active therapeutic release with rapid absorption and high safety profile.

Dosage & Administration Guidance

Proper usage directions under clinical supervision

As directed by the physician or healthcare professional. Take with water at prescribed intervals.

Precautions, Warnings & Contraindications

Safety guidelines and patient health considerations

Clinical Safety & Medical Advice:

Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.

Possible Side Effects

Tolerability profile and reporting

Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.

Storage & Handling Instructions

Maintaining formulation stability and shelf-life

Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.

Exclusive PCD Pharma Franchise Opportunity for ULCRIO

Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for ULCRIO across India with comprehensive visual aids, prompt dispatch, and high profit margins.

Frequently Asked Questions (FAQs)

Common queries regarding ULCRIO

What is ULCRIO used for?
ULCRIO is prescribed for Aphthous Ulcers & Painful Mouth Sores /Teething Pain & Denture Irritation. Always follow physician dosage instructions.
What is the printed packaging and MRP of ULCRIO?
The printed packaging is 10gm with an MRP of ₹72.00.
How can I get monopoly PCD franchise for ULCRIO?
You can request district monopoly rights directly via sales@riomedicahealthcare.com or WhatsApp +91 82229 99973.
×

PCD Franchise Enquiry

Get monopoly rights, wholesale price list & free promotional visual aids.